1
|
Abuhaimed A, Mujammami H, AlEnazi K, Abanomy A, Alashban Y, Martin CJ. Estimation of organ and effective doses of CBCT scans of radiotherapy using size-specific field of view (FOV): a Monte Carlo study. Phys Eng Sci Med 2024; 47:895-906. [PMID: 38536632 DOI: 10.1007/s13246-024-01413-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2023] [Accepted: 03/04/2024] [Indexed: 09/18/2024]
Abstract
The kV cone beam computed tomography (CBCT) is one of the most common imaging modalities used for image-guided radiation therapy (IGRT) procedures. Additional doses are delivered to patients, thus assessment and optimization of the imaging doses should be taken into consideration. This study aimed to investigate the influence of using fixed and patient-specific FOVs on the patient dose. Monte Carlo simulations were performed to simulate kV beams of the imaging system integrated into Truebeam linear accelerator using BEAMnrc code. Organ and size-specific effective doses resulting from chest and pelvis scanning protocols were estimated with DOSXYZnrc code using a phantom library developed by the National Cancer Institute (NCI) of the US. The library contains 193 (100 male and 93 female) mesh-type computational human adult phantoms, and it covers a large ratio of patient sizes with heights and weights ranging from 150 to 190 cm and 40 to 125 kg. The imaging doses were assessed using variable FOV of three sizes, small (S), medium (M), and large (L) for each scan region. The results show that the FOV and the patient size played a major role in the scan dose. The average percentage differences (PDs) for doses of organs that were fully inside the different FOVs were relatively low, all within 11% for both protocols. However, doses to organs that were scanned partially or near the FOVs were affected significantly. For the chest protocol, the inclusion of the thyroid in the scan field could give a dose of 1-7 mGy/100 mAs to the thyroid, compared to 0.4-1 mGy/100 mAs when it was excluded. Similarly, on average, testes doses could be 6 mGy/100 mAs for the male pelvis protocol compared to 3 mGy/100 mAs when it did not lie in the field irradiated. These dose differences resulted in an average increase of up to 27% in the size-specific effective dose of the protocols. Since changing the field size is possible for CBCT scans, the results suggest that patient-specific scanning protocols could be applied for each scan area in a manner similar to that used for CT scans. Adjustment of the FOV size should be subject to the clinical needs, and assist in improving the treatment accuracy. The patient's height and weight might be considered as the main factors upon which, the selection of the appropriate patient-specific protocol is based. This approach should optimize the imaging doses used for IGRT procedures by minimizing doses of a large ratio of patients.
Collapse
Affiliation(s)
- Abdullah Abuhaimed
- King Abdulaziz City for Science and Technology (KACST), P.O Box 6086, 11442, Riyadh, Saudi Arabia.
| | - Huda Mujammami
- Radiological Sciences Department, College of Applied Medical Sciences, King Saud University, P.O. Box 145111, 4545, Riyadh, Saudi Arabia
| | - Khaled AlEnazi
- Radiological Sciences Department, College of Applied Medical Sciences, King Saud University, P.O. Box 145111, 4545, Riyadh, Saudi Arabia
| | - Ahmed Abanomy
- Radiological Sciences Department, College of Applied Medical Sciences, King Saud University, P.O. Box 145111, 4545, Riyadh, Saudi Arabia
| | - Yazeed Alashban
- Radiological Sciences Department, College of Applied Medical Sciences, King Saud University, P.O. Box 145111, 4545, Riyadh, Saudi Arabia
| | - Colin J Martin
- Department of Clinical Physics and Bio-Engineering, Gartnavel Royal Hospital, University of Glasgow, Glasgow, G12 8QQ, UK
| |
Collapse
|
2
|
Abuhaimed A, Martin CJ. Assessment of organ and size-specific effective doses from cone beam CT (CBCT) in image-guided radiotherapy (IGRT) based on body mass index (BMI). Radiat Phys Chem Oxf Engl 1993 2023. [DOI: 10.1016/j.radphyschem.2023.110889] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/06/2023]
|
3
|
Porzio M, Anam C. Real-time fully automated dosimetric computation for CT images in the clinical workflow: A feasibility study. Front Oncol 2022; 12:798460. [PMID: 36033538 PMCID: PMC9403986 DOI: 10.3389/fonc.2022.798460] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2021] [Accepted: 07/19/2022] [Indexed: 11/13/2022] Open
Abstract
Background Currently, the volume computed tomography dose index (CTDIvol), the most-used quantity to express the output dose of a computed tomography (CT) patient’s dose, is not related to the real size and attenuation properties of each patient. The size-specific dose estimates (SSDE), based on the water-equivalent diameter (DW) overcome those issues. The proposed methods found in the literature do not allow real-time computation of DW and SSDE. Purpose This study aims to develop a software to compute DW and SSDE in a real-time clinical workflow. Method In total, 430 CT studies and scans of a water-filled funnel phantom were used to compute accuracy and evaluate the times required to compute the DW and SSDE. Two one-sided tests (TOST) equivalence test, Bland–Altman analysis, and bootstrap-based confidence interval estimations were used to evaluate the differences between actual diameter and DW computed automatically and between DW computed automatically and manually. Results The mean difference between the DW computed automatically and the actual water diameter for each slice is −0.027% with a TOST confidence interval equal to [−0.087%, 0.033%]. Bland–Altman bias is −0.009% [−0.016%, −0.001%] with lower limits of agreement (LoA) equal to −0.0010 [−0.094%, −0.068%] and upper LoA equal to 0.064% [0.051%, 0.077%]. The mean difference between DW computed automatically and manually is −0.014% with a TOST confidence interval equal to [−0.056%, 0.028%] on phantom and 0.41% with a TOST confidence interval equal to [0.358%, 0.462%] on real patients. The mean time to process a single image is 13.99 ms [13.69 ms, 14.30 ms], and the mean time to process an entire study is 11.5 s [10.62 s, 12.63 s]. Conclusion The system shows that it is possible to have highly accurate DW and SSDE in almost real-time without affecting the clinical workflow of CT examinations.
Collapse
Affiliation(s)
- Massimiliano Porzio
- Department of Fisica Sanitaria, Azienda Sanitaria Locale Cuneo1 (ASL CN1), Cuneo, Italy
- *Correspondence: Massimiliano Porzio,
| | - Choirul Anam
- Department of Physics, Faculty of Sciences and Mathematics, Diponegoro University, Semarang, Indonesia
| |
Collapse
|
4
|
Gilling L, Ali O. Organ dose from Varian XI and Varian OBI systems are clinically comparable for pelvic CBCT imaging. Phys Eng Sci Med 2022; 45:279-285. [PMID: 35143026 DOI: 10.1007/s13246-021-01090-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2021] [Accepted: 12/07/2021] [Indexed: 11/27/2022]
Abstract
Pelvic cone-beam computed tomography (CBCT) occurs daily in many radiotherapy clinics as a part of image-guided verification before treatment. These images are acquired by the use of ionizing radiation. The dose received by CBCT imaging is often not quantified in a patient's radiation therapy prescription. The purpose of this work was to quantify the dose from a TrueBeam XI pelvic CBCT imaging system. The dose to organs from this imaging protocol was then compared with published dose data for OBI v1.4 pelvic CBCT imaging. A model of the Varian XI imager was constructed using GATE Monte Carlo scripting language. The model was calibrated by correlation with experimental measurements. An IBA 3D water tank was used to perform relative dose measurements in water. An adult anthropomorphic Alderson phantom with embedded thermolumeniscent dosimeters was used to evaluate dose from prostate CBCT imaging. Following the calibration, the GATE model was used to simulate the dose from the XI pelvic CBCT protocol to the ICRP computational anthropomorphic phantom. The Monte Carlo model constructed in GATE was validated for use in dose estimates for the XI pelvic imaging protocol. The D50 and D10 values tabulated the pelvic CBCT protocol show that doses to organs in the pelvic region are comparable for both systems. For a clinician who intends to evaluate the dose to organs as a result of CBCT imaging of the pelvis from the TrueBeam XI system, for the purposes of treatment planning, the doses reported for OBI v1.4 given in AAPM TG-180 provide a valid estimate.
Collapse
Affiliation(s)
- Luke Gilling
- Medical Physics Department, Waikato District Health Board, Hamilton, New Zealand.
| | - Omer Ali
- Medical Physics Department, Waikato District Health Board, Hamilton, New Zealand
| |
Collapse
|
5
|
Ordóñez-Sanz C, Cowen M, Shiravand N, MacDougall ND. CBCT imaging: a simple approach for optimising and evaluating concomitant imaging doses, based on patient-specific attenuation, during radiotherapy pelvis treatment. Br J Radiol 2021; 94:20210068. [PMID: 34282947 PMCID: PMC8523193 DOI: 10.1259/bjr.20210068] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Objectives: A simple, robust method, for optimising cone-beam CT (CBCT) dose and image quality for pelvis treatment, based on patient-specific attenuation. Methods: Methods were investigated for grouping patients into four imaging categories (small [S], medium [M], large [L], extra large [XL]), based on planning-CT CTDIvol, and phantoms constructed to represent each group. CBCTs with varying kV, mA and ms honed in on the best settings, with a bladder noise of 25 HU. A patient pilot study clinically verified the new imaging settings. Results: The planning CTDIvol is a reliable method for grouping patients. Phantom measurements from the S, M and L groups show doses significantly reduced (19–83% reduction), whilst the XL group required an increase of 39%. Phantom TLD measurements showed the number of scans needed to increase rectal organ at risk (OAR) dose by 1 Gy was 143 (S group) and 50 (M group). Images were qualitatively assessed as sufficient by clinicians. Conclusion: Patient-specific CBCT modes are in use clinically with dose reductions across all modes except Pelvis XL, keeping doses ALARP and images optimal. Consideration of OAR doses controls the number of CBCTs allowed to ensure adherence to OAR tolerance. Reporting CBCT doses in “scans per Gray” allows clinicians to make informed decisions regarding the imaging schedule and concomitant doses. Advances in knowledge: Patient grouping at planning CT, using CTDIvol, allows for CBCT imaging protocols to be selected based on patient specific attenuation. Reporting OAR doses in terms of “scans per Gray” allows translation of imaging dose risk to the Oncologist.
Collapse
Affiliation(s)
| | - Mark Cowen
- North West Anglia NHS Foundation Trust, England, UK
| | - Neda Shiravand
- Radiotherapy Physics, St Bartholomew's Hospital, London, UK
| | - Niall D MacDougall
- Radiotherapy Physics, St Bartholomew's Hospital, London, UK.,Barts Cancer Institute, Queen Mary University of London, London, UK
| |
Collapse
|
6
|
Hua CH, Vern-Gross TZ, Hess CB, Olch AJ, Alaei P, Sathiaseelan V, Deng J, Ulin K, Laurie F, Gopalakrishnan M, Esiashvili N, Wolden SL, Krasin MJ, Merchant TE, Donaldson SS, FitzGerald TJ, Constine LS, Hodgson DC, Haas-Kogan DA, Mahajan A, Laack N, Marcus KJ, Taylor PA, Ahern VA, Followill DS, Buchsbaum JC, Breneman JC, Kalapurakal JA. Practice patterns and recommendations for pediatric image-guided radiotherapy: A Children's Oncology Group report. Pediatr Blood Cancer 2020; 67:e28629. [PMID: 32776500 PMCID: PMC7774502 DOI: 10.1002/pbc.28629] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/05/2020] [Revised: 06/16/2020] [Accepted: 07/19/2020] [Indexed: 12/18/2022]
Abstract
This report by the Radiation Oncology Discipline of Children's Oncology Group (COG) describes the practice patterns of pediatric image-guided radiotherapy (IGRT) based on a member survey and provides practice recommendations accordingly. The survey comprised of 11 vignettes asking clinicians about their recommended treatment modalities, IGRT preferences, and frequency of in-room verification. Technical questions asked physicists about imaging protocols, dose reduction, setup correction, and adaptive therapy. In this report, the COG Radiation Oncology Discipline provides an IGRT modality/frequency decision tree and the expert guidelines for the practice of ionizing image guidance in pediatric radiotherapy patients.
Collapse
Affiliation(s)
- Chia-ho Hua
- Department of Radiation Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee
| | | | - Clayton B. Hess
- Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts
- Department of Radiation Oncology, Emory University, Atlanta, Georgia
| | - Arthur J. Olch
- Department of Radiation Oncology, University of Southern California and Children’s Hospital of Los Angeles, Los Angeles, California
| | - Parham Alaei
- Department of Radiation Oncology, University of Minnesota, Minneapolis, Minnesota
| | | | - Jun Deng
- Department of Therapeutic Radiology, Yale University, New Haven, Connecticut
| | - Kenneth Ulin
- Department of Radiation Oncology, University of Massachusetts, Worcester, Massachusetts
| | - Fran Laurie
- Department of Radiation Oncology, University of Massachusetts, Worcester, Massachusetts
| | | | - Natia Esiashvili
- Department of Radiation Oncology, Emory University, Atlanta, Georgia
| | - Suzanne L. Wolden
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Matthew J. Krasin
- Department of Radiation Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee
| | - Thomas E Merchant
- Department of Radiation Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee
| | - Sarah S. Donaldson
- Department of Radiation Oncology, Stanford University, Stanford, California
| | - Thomas J. FitzGerald
- Department of Radiation Oncology, University of Massachusetts, Worcester, Massachusetts
| | - Louis S. Constine
- Department of Radiation Oncology, University of Rochester, Rochester, New York
| | - David C. Hodgson
- Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
| | - Daphne A. Haas-Kogan
- Department of Radiation Oncology, Dana Farber Cancer Institute/Boston Children’s Hospital, Boston, Massachusetts
| | - Anita Mahajan
- Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota
| | - Nadia Laack
- Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota
| | - Karen J. Marcus
- Department of Radiation Oncology, Dana Farber Cancer Institute/Boston Children’s Hospital, Boston, Massachusetts
| | - Paige A Taylor
- Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
| | - Verity A Ahern
- Department of Radiation Oncology, Children’s Hospital at Westmead, Sydney, Australia
| | - David S. Followill
- Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
| | - Jeffrey C. Buchsbaum
- Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland
| | - John C. Breneman
- Department of Radiation Oncology, University of Cincinnati, Cincinnati, Ohio
| | - John A. Kalapurakal
- Department of Radiation Oncology, Northwestern University, Chicago, Illinois
| |
Collapse
|
7
|
Boissonnat G, Chesneau H, Barat E, Dautremer T, Garcia-Hernandez JC, Lazaro D. Validation of histogram-based virtual source models for different IGRT kV-imaging systems. Med Phys 2020; 47:4531-4542. [PMID: 32497267 DOI: 10.1002/mp.14311] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2019] [Revised: 05/24/2020] [Accepted: 05/26/2020] [Indexed: 11/09/2022] Open
Abstract
PURPOSE Image-guided radiotherapy (IGRT) improves tumor control but its intensive use may entrain late side effects caused by the additional imaging doses. There is a need to better quantify the additional imaging doses, so they can be integrated in the therapeutic workflow. Currently, no dedicated software enables to compute patient-specific imaging doses on a wide range of systems and protocols. As a first step toward this objective, we propose a common methodology to model four different kV-imaging systems used in radiotherapy (Varian's OBI, Elekta's XVI, Brainlab's ExacTrac, and Accuray's Cyberknife) using a new type of virtual source model based on Monte Carlo calculations. METHODS We first describe our method to build a simplified description of the photon output, or virtual source models (VSMs), of each imaging system. Instead of being constructed using measurement data, as it is most commonly the case, our VSM is used as the summary of the phase-space files (PSFs) resulting from a first Monte Carlo simulation of the considered x-ray tube. Second, the VSM is used as a photon generator for a second MC simulation in which we compute the dose. Then, the proposed VSM is thoroughly validated against standard MC simulation using PSFs on the XVI system. Last, each modeled system is compared to profiles and depth-dose-curve measurements performed in homogeneous phantom. RESULTS Comparisons between PSF-based and VSM-based calculations highlight that VSMs could provide equivalent dose results (within 1% of difference) than PSFs inside the imaging field-of-view (FOV). In contrast, VSMs tend to underestimate (for up to 20%) calculated doses outside of the imaging FOV due to the assumptions underlying the VSM construction. In addition, we showed that the use of VSMs allows reducing calculation time by at least a factor of 2.8. Indeed, for identical simulation times, statistical uncertainties on dose distributions computed using VSMs were much lower than those obtained from PSF-based calculations. CONCLUSIONS For each of the four imaging systems, VSMs were successfully validated against measurements in homogeneous phantoms, and are therefore ready to be used for future preclinical studies in heterogeneous or anthropomorphic phantoms. The cross system modeling methodology developed here should enable, later on, to estimate precisely and accurately patient-specific 3D dose maps delivered during a large range of kV-imaging procedures.
Collapse
Affiliation(s)
- G Boissonnat
- CEA, LIST, System Modelling and Simulation Lab, Gif-sur-Yvette, F-91191, France
| | - H Chesneau
- CEA, LIST, System Modelling and Simulation Lab, Gif-sur-Yvette, F-91191, France
| | - E Barat
- CEA, LIST, System Modelling and Simulation Lab, Gif-sur-Yvette, F-91191, France
| | - T Dautremer
- CEA, LIST, System Modelling and Simulation Lab, Gif-sur-Yvette, F-91191, France
| | | | - D Lazaro
- CEA, LIST, System Modelling and Simulation Lab, Gif-sur-Yvette, F-91191, France
| |
Collapse
|
8
|
Moeckli R, Baillod A, Gibellieri D, Conrad M, Marsolat F, Schiappacasse L, Jumeau R, Jeanneret‐Sozzi W, Bourhis J, Bochud FO, Germond J. Dose indicator for CyberKnife image‐guided radiation therapy. Med Phys 2020; 47:2309-2316. [DOI: 10.1002/mp.14103] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2019] [Revised: 02/14/2020] [Accepted: 02/14/2020] [Indexed: 11/06/2022] Open
Affiliation(s)
- Raphaël Moeckli
- Institute of Radiation Physics Lausanne University Hospital Rue du Grand‐Pré 1 CH‐1007Lausanne Switzerland
| | - Antoine Baillod
- Institute of Radiation Physics Lausanne University Hospital Rue du Grand‐Pré 1 CH‐1007Lausanne Switzerland
| | - Dora Gibellieri
- Institute of Radiation Physics Lausanne University Hospital Rue du Grand‐Pré 1 CH‐1007Lausanne Switzerland
| | - Mireille Conrad
- Department of Nuclear and Corpuscular Physics University of Geneva Quai Ernest‐Ansermet 24 CH‐1211Geneva Switzerland
| | - Fanny Marsolat
- Institute of Radiation Physics Lausanne University Hospital Rue du Grand‐Pré 1 CH‐1007Lausanne Switzerland
| | - Luis Schiappacasse
- Department of Radiation Oncology Lausanne University Hospital Rue du Bugnon 46 CH‐1011Lausanne Switzerland
| | - Raphaël Jumeau
- Department of Radiation Oncology Lausanne University Hospital Rue du Bugnon 46 CH‐1011Lausanne Switzerland
| | - Wendy Jeanneret‐Sozzi
- Department of Radiation Oncology Lausanne University Hospital Rue du Bugnon 46 CH‐1011Lausanne Switzerland
| | - Jean Bourhis
- Department of Radiation Oncology Lausanne University Hospital Rue du Bugnon 46 CH‐1011Lausanne Switzerland
| | - François O. Bochud
- Institute of Radiation Physics Lausanne University Hospital Rue du Grand‐Pré 1 CH‐1007Lausanne Switzerland
| | - Jean‐François Germond
- Institute of Radiation Physics Lausanne University Hospital Rue du Grand‐Pré 1 CH‐1007Lausanne Switzerland
| |
Collapse
|
9
|
Poirier Y, Johnstone CD, Anvari A, Brodin NP, Santos MD, Bazalova-Carter M, Sawant A. A failure modes and effects analysis quality management framework for image-guided small animal irradiators: A change in paradigm for radiation biology. Med Phys 2020; 47:2013-2022. [PMID: 31986221 DOI: 10.1002/mp.14049] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2019] [Revised: 12/17/2019] [Accepted: 01/10/2020] [Indexed: 12/28/2022] Open
Abstract
PURPOSE Image-guided small animal irradiators (IGSAI) are increasingly being adopted in radiation biology research. These animal irradiators, designed to deliver radiation with submillimeter accuracy, exhibit complexity similar to that of clinical radiation delivery systems, including image guidance, robotic stage motion, and treatment planning systems. However, physics expertise and resources are scarcer in radiation biology, which makes implementation of conventional prescriptive QA infeasible. In this study, we apply the failure modes and effect analysis (FMEA) popularized by the AAPM task group 100 (TG-100) report to IGSAI and radiation biological research. METHODS Radiation biological research requires a change in paradigm where small errors to large populations of animals are more severe than grievous errors that only affect individuals. To this end, we created a new adverse effects severity table adapted to radiation biology research based on the original AAPM TG-100 severity table. We also produced a process tree which outlines the main components of radiation biology studies performed on an IGSAI, adapted from the original clinical IMRT process tree from TG-100. Using this process tree, we created and distributed a preliminary survey to eight expert IGSAI operators in four institutions. Operators rated proposed failure modes for occurrence, severity, and lack of detectability, and were invited to share their own experienced failure modes. Risk probability numbers (RPN) were calculated and used to identify the failure modes which most urgently require intervention. RESULTS Surveyed operators indicated a number of high (RPN >125) failure modes specific to small animal irradiators. Errors due to equipment breakdown, such as loss of anesthesia or thermal control, received relatively low RPN (12-48) while errors related to the delivery of radiation dose received relatively high RPN (72-360). Errors identified could either be improved by manufacturer intervention (e.g., electronic interlocks for filter/collimator) or physics oversight (errors related to tube calibration or treatment planning system commissioning). Operators identified a number of failure modes including collision between the collimator and the stage, misalignment between imaging and treatment isocenter, inaccurate robotic stage homing/translation, and incorrect SSD applied to hand calculations. These were all relatively highly rated (90-192), indicating a possible bias in operators towards reporting high RPN failure modes. CONCLUSIONS The first FMEA specific to radiation biology research was applied to image-guided small animal irradiators following the TG-100 methodology. A new adverse effects severity table and a process tree recognizing the need for a new paradigm were produced, which will be of great use to future investigators wishing to pursue FMEA in radiation biology research. Future work will focus on expanding scope of user surveys to users of all commercial IGSAI and collaborating with manufacturers to increase the breadth of surveyed expert operators.
Collapse
Affiliation(s)
- Yannick Poirier
- Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA
| | - Christopher Daniel Johnstone
- Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA.,Department of Physics and Astronomy, University of Victoria, Victoria, BC, Canada
| | - Akbar Anvari
- Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA
| | - N Patrik Brodin
- Department of Radiation Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY, USA
| | - Morgane Dos Santos
- Service de Recherche en Radiobiologie et en Médecine régénérative, Laboratoire de Radiobiologie des expositions Accidentelles, Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Fontenay-aux-Roses, France
| | | | - Amit Sawant
- Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA
| |
Collapse
|
10
|
Bell K, Licht N, Rübe C, Dzierma Y. Image guidance and positioning accuracy in clinical practice: influence of positioning errors and imaging dose on the real dose distribution for head and neck cancer treatment. Radiat Oncol 2018; 13:190. [PMID: 30285806 PMCID: PMC6167812 DOI: 10.1186/s13014-018-1141-8] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2018] [Accepted: 09/24/2018] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Modern radiotherapy offers the possibility of highly accurate tumor treatment. To benefit from this precision at its best, regular positioning verification is necessary. By the use of image-guided radiotherapy and the application of safety margins the influence of positioning inaccuracies can be counteracted. In this study the effect of additional imaging dose by set-up verification is compared with the effect of dose smearing by positioning inaccuracies for a collective of head-and-neck cancer patients. METHODS This study is based on treatment plans of 40 head-and-neck cancer patients. To evaluate the imaging dose several image guidance scenarios with different energies, techniques and frequencies were simulated and added to the original plan. The influence of the positioning inaccuracies was assessed by the use of real applied table shifts for positioning. The isocenters were shifted back appropriately to these values to simulate that no positioning correction had been performed. For the single fractions the shifted plans were summed considering three different scenarios: The summation of only shifted plans, the consideration of the original plan for the fractions with set-up verification, and the addition of the extra imaging dose to the latter. For both effects (additional imaging dose and dose smearing), plans were analyzed and compared considering target coverage, sparing of organs at risk (OAR) and normal tissue complication probability (NTCP). RESULTS Daily verification of the patient positioning using 3D imaging with MV energies result in non-negligible high doses. kV imaging has only marginal influence on plan quality, primarily related to sparing of organs at risk, even with daily 3D imaging. For this collective, sparing of organs at risk and NTCP are worse due to potential positioning errors. CONCLUSION Regular set-up verification is essential for precise radiation treatment. Relating to the additional dose, the use of kV modalities is uncritical for any frequency and technique. Dose smearing due to positioning errors for this collective mainly resulted in a decrease of OAR sparing. Target coverage also suffered from the positioning inaccuracies, especially for individual patients. Taking into account both examined effects the relevance of an extensive IGRT is clearly present, even at the expense of additional imaging dose and time expenditure.
Collapse
Affiliation(s)
- Katharina Bell
- Department of Radiotherapy and Radiation Oncology, Saarland University Medical Centre, Kirrberger Str. Geb. 6.5/Saar, D-66421 Homburg, Germany
| | - Norbert Licht
- Department of Radiotherapy and Radiation Oncology, Saarland University Medical Centre, Kirrberger Str. Geb. 6.5/Saar, D-66421 Homburg, Germany
| | - Christian Rübe
- Department of Radiotherapy and Radiation Oncology, Saarland University Medical Centre, Kirrberger Str. Geb. 6.5/Saar, D-66421 Homburg, Germany
| | - Yvonne Dzierma
- Department of Radiotherapy and Radiation Oncology, Saarland University Medical Centre, Kirrberger Str. Geb. 6.5/Saar, D-66421 Homburg, Germany
| |
Collapse
|
11
|
Ding GX, Alaei P, Curran B, Flynn R, Gossman M, Mackie TR, Miften M, Morin R, Xu XG, Zhu TC. Image guidance doses delivered during radiotherapy: Quantification, management, and reduction: Report of the AAPM Therapy Physics Committee Task Group 180. Med Phys 2018; 45:e84-e99. [PMID: 29468678 DOI: 10.1002/mp.12824] [Citation(s) in RCA: 75] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2017] [Revised: 01/10/2018] [Accepted: 01/10/2018] [Indexed: 11/07/2022] Open
Abstract
BACKGROUND With radiotherapy having entered the era of image guidance, or image-guided radiation therapy (IGRT), imaging procedures are routinely performed for patient positioning and target localization. The imaging dose delivered may result in excessive dose to sensitive organs and potentially increase the chance of secondary cancers and, therefore, needs to be managed. AIMS This task group was charged with: a) providing an overview on imaging dose, including megavoltage electronic portal imaging (MV EPI), kilovoltage digital radiography (kV DR), Tomotherapy MV-CT, megavoltage cone-beam CT (MV-CBCT) and kilovoltage cone-beam CT (kV-CBCT), and b) providing general guidelines for commissioning dose calculation methods and managing imaging dose to patients. MATERIALS & METHODS We briefly review the dose to radiotherapy (RT) patients resulting from different image guidance procedures and list typical organ doses resulting from MV and kV image acquisition procedures. RESULTS We provide recommendations for managing the imaging dose, including different methods for its calculation, and techniques for reducing it. The recommended threshold beyond which imaging dose should be considered in the treatment planning process is 5% of the therapeutic target dose. DISCUSSION Although the imaging dose resulting from current kV acquisition procedures is generally below this threshold, the ALARA principle should always be applied in practice. Medical physicists should make radiation oncologists aware of the imaging doses delivered to patients under their care. CONCLUSION Balancing ALARA with the requirement for effective target localization requires that imaging dose be managed based on the consideration of weighing risks and benefits to the patient.
Collapse
Affiliation(s)
- George X Ding
- Department of Radiation Oncology, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA
| | - Parham Alaei
- University of Minnesota, Minneapolis, MN, 55455, USA
| | - Bruce Curran
- Virginia Commonwealth University, Richmond, VA, 23284, USA
| | - Ryan Flynn
- University of Iowa, Iowa City, IA, 52242, USA
| | | | | | | | | | - X George Xu
- Rensselaer Polytechnic Institute, Troy, NY, 12180, USA
| | - Timothy C Zhu
- University of Pennsylvania, Philadelphia, PA, 19104, USA
| |
Collapse
|
12
|
Abuhaimed A, Martin CJ, Sankaralingam M. A Monte Carlo study of organ and effective doses of cone beam computed tomography (CBCT) scans in radiotherapy. JOURNAL OF RADIOLOGICAL PROTECTION : OFFICIAL JOURNAL OF THE SOCIETY FOR RADIOLOGICAL PROTECTION 2018; 38:61-80. [PMID: 28952463 DOI: 10.1088/1361-6498/aa8f61] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Cone-beam CT (CBCT) scans utilised for image guided radiation therapy (IGRT) procedures have become an essential part of radiotherapy. The aim of this study was to assess organ and effective doses resulting from new CBCT scan protocols (head, thorax, and pelvis) released with a software upgrade of the kV on-board-imager (OBI) system. Organ and effective doses for protocols of the new software (V2.5) and a previous version (V1.6) were assessed using Monte Carlo (MC) simulations for the International Commission on Radiological Protection (ICRP) adult male and female reference computational phantoms. The number of projections and the mAs values were increased and the size of the scan field was extended in the new protocols. Influence of these changes on organ and effective doses of the scans was investigated. The OBI system was modelled in EGSnrc/BEAMnrc, and organ doses were estimated using EGSnrc/DOSXYZnrc. The MC model was benchmarked against experimental measurements. Organ doses resulting from the V2.5 protocols were higher than those of V1.6 for organs that were partially or fully inside the scans fields, and increased by (3-13)%, (10-77)%, and (13-21)% for the head, thorax, and pelvis protocols for both phantoms, respectively. As a result, effective doses rose by 14%, 17%, and 16% for the male phantom, and 13%, 18%, and 17% for the female phantom for the three scan protocols, respectively. The scan field extension for the V2.5 protocols contributed significantly in the dose increases, especially for organs that were partially irradiated such as the thyroid in head and thorax scans and colon in the pelvic scan. The contribution of the mAs values and projection numbers was minimal in the dose increases, up to 2.5%. The field size extension plays a major role in improving the treatment output by including more markers in the field of view to match between CBCT and CT images and hence setting up the patient precisely. Therefore, a trade-off between the risk and benefits of CBCT scans should be considered, and the dose increases should be monitored. Several recommendations have been made for optimisation of the patient dose involved for IGRT procedures.
Collapse
Affiliation(s)
- Abdullah Abuhaimed
- The National Centre for Applied Physics, King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia
| | | | | |
Collapse
|
13
|
Conrad M, Bolard G, Nowak M, De Bari B, Jeanneret-Sozzi W, Bourhis J, Germond JF, Bochud F, Moeckli R. Determination of the effective dose delivered by image guided radiotherapy in head & neck and breast treatments. Z Med Phys 2018; 28:276-285. [PMID: 29426589 DOI: 10.1016/j.zemedi.2018.01.001] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2017] [Revised: 11/23/2017] [Accepted: 01/03/2018] [Indexed: 11/24/2022]
Abstract
PURPOSE Image guided radiotherapy (IGRT) improves patient positioning for treatment delivery at the cost of an additional dose. This work aimed to calculate the effective dose (as an indicator of dose) for head & neck (H&N) and breast IGRT treatments by implementing dose calculation models to determine the dose distributions. METHODS The kV dose-models were created for the IGRT systems of Elekta Synergy (XVI) and Varian Clinac (OBI) linear accelerators within Philips Pinnacle TPS. Profiles and depth dose curves were measured in water. The models were validated in a CIRS thorax phantom. The IGRT dose distributions for five H&N and five breast patients were calculated. The effective dose was determined from the dose distributions following ICRP 103 recommendations. Moreover, time-saving approximations were studied in order to propose an alternative way of segmenting the tissues for a clinical implementation of the method. RESULTS AND CONCLUSION The effective dose specifically associated with IGRT varied from 1 to 10mSv depending on the protocol. The kV dose-model allowed us to calculate the dose distributions from IGRT for different configurations and patients, and to determine effective dose for IGRT protocols. The clinical implementation of the method was found to reduce time and to introduce a small enough increase of uncertainty in the results to be clinically usable.
Collapse
Affiliation(s)
- Mireille Conrad
- Institute of Radiation Physics, Lausanne University Hospital, Lausanne, Switzerland; University of Geneva, Geneva, Switzerland
| | | | - Marie Nowak
- Institute of Radiation Physics, Lausanne University Hospital, Lausanne, Switzerland
| | - Berardino De Bari
- Department of Radio-Oncology, Lausanne University Hospital, Lausanne, Switzerland
| | | | - Jean Bourhis
- Department of Radio-Oncology, Lausanne University Hospital, Lausanne, Switzerland
| | | | - François Bochud
- Institute of Radiation Physics, Lausanne University Hospital, Lausanne, Switzerland
| | - Raphaël Moeckli
- Institute of Radiation Physics, Lausanne University Hospital, Lausanne, Switzerland.
| |
Collapse
|
14
|
Alnewaini Z, Langer E, Schaber P, David M, Kretz D, Steil V, Hesser J. Real-time, ray casting-based scatter dose estimation for c-arm x-ray system. J Appl Clin Med Phys 2017; 18:144-153. [PMID: 28300387 PMCID: PMC5689942 DOI: 10.1002/acm2.12036] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2016] [Accepted: 09/08/2016] [Indexed: 11/09/2022] Open
Abstract
Objectives Dosimetric control of staff exposure during interventional procedures under fluoroscopy is of high relevance. In this paper, a novel ray casting approximation of radiation transport is presented and the potential and limitation vs. a full Monte Carlo transport and dose measurements are discussed. Method The x‐ray source of a Siemens Axiom Artix C‐arm is modeled by a virtual source model using single Gaussian‐shaped source. A Geant4‐based Monte Carlo simulation determines the radiation transport from the source to compute scatter from the patient, the table, the ceiling and the floor. A phase space around these scatterers stores all photon information. Only those photons are traced that hit a surface of phantom that represents medical staff in the treatment room, no indirect scattering is considered; and a complete dose deposition on the surface is calculated. To evaluate the accuracy of the approximation, both experimental measurements using Thermoluminescent dosimeters (TLDs) and a Geant4‐based Monte Carlo simulation of dose depositing for different tube angulations of the C‐arm from cranial‐caudal angle 0° and from LAO (Left Anterior Oblique) 0°–90° are realized. Since the measurements were performed on both sides of the table, using the symmetry of the setup, RAO (Right Anterior Oblique) measurements were not necessary. Results The Geant4‐Monte Carlo simulation agreed within 3% with the measured data, which is within the accuracy of measurement and simulation. The ray casting approximation has been compared to TLD measurements and the achieved percentage difference was −7% for data from tube angulations 45°–90° and −29% from tube angulations 0°–45° on the side of the x‐ray source, whereas on the opposite side of the x‐ray source, the difference was −83.8% and −75%, respectively. Ray casting approximation for only LAO 90° was compared to a Monte Carlo simulation, where the percentage differences were between 0.5–3% on the side of the x‐ray source where the highest dose usually detected was mainly from primary scattering (photons), whereas percentage differences between 2.8–20% are found on the side opposite to the x‐ray source, where the lowest doses were detected. Dose calculation time of our approach was 0.85 seconds. Conclusion The proposed approach yields a fast scatter dose estimation where we could run the Monte Carlo simulation only once for each x‐ray tube angulation to get the Phase Space Files (PSF) for being used later by our ray casting approach to calculate the dose from only photons which will hit an movable elliptical cylinder shaped phantom and getting an output file for the positions of those hits to be used for visualizing the scatter dose propagation on the phantom surface. With dose calculation times of less than one second, we are saving much time compared to using a Monte Carlo simulation instead. With our approach, larger deviations occur only in regions with very low doses, whereas it provides a high precision in high‐dose regions.
Collapse
Affiliation(s)
- Zaid Alnewaini
- Department of Radiation Oncology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany
| | - Eric Langer
- Institute and Outpatient Clinic for Diagnostic Radiology, University Hospital Dresden, Dresden, Germany
| | - Philipp Schaber
- Department of Computer Science IV, University of Mannheim, Mannheim, Germany
| | - Matthias David
- Computer Assisted Clinical Medicine, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany
| | - Dominik Kretz
- Department of Radiation Oncology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany
| | - Volker Steil
- Department of Radiation Oncology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany
| | - Jürgen Hesser
- Department of Radiation Oncology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany
| |
Collapse
|
15
|
Bell K, Heitfeld M, Licht N, Rübe C, Dzierma Y. Influence of daily imaging on plan quality and normal tissue toxicity for prostate cancer radiotherapy. Radiat Oncol 2017; 12:7. [PMID: 28069053 PMCID: PMC5223448 DOI: 10.1186/s13014-016-0757-9] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2016] [Accepted: 12/28/2016] [Indexed: 11/10/2022] Open
Abstract
Background Modern radiotherapy offers various possibilities for image guided verification of patient positioning. Different clinically relevant IGRT (image guided radiotherapy) scenarios were considered with regard to their influence on dosimetric plan quality and normal tissue complication probability (NTCP). Methods This study is based on treatment plans of 50 prostate patients. We evaluate the clinically performed IGRT and simulate the influence of different daily IGRT scenarios on plan quality. Imaging doses of planar and cone-beam-CT (CBCT) images for three different energies (6 MV, 1 MV and 121 kV) were added to the treatment plans. The plan quality of the different scenarios was assessed by a visual inspection of the dose distribution and dose-volume-histogram (DVH) and a statistical analysis of DVH criteria. In addition, an assessment of the normal tissue complication probability was performed. Results Daily 1MV-CBCTs result in undesirable high dose regions in the target volume. The DVH shows that the scenarios with actual imaging performed, daily kV-CBCT and daily 6MV imaging (1x CBCT, 4x planar images per week) do not differ exceedingly from the original plan; especially imaging with daily kV-CBCT has little influence to the sparing of organs at risk. In contrast, daily 1MV- CBCT entails an additional dose of up to two fraction doses. Due to the additional dose amount some DVH constraints for plan acceptability could no longer be satisfied, especially for the daily 1MV-CBCT scenario. This scenario also shows increased NTCP for the rectum. Conclusion Daily kV-CBCT has negligible influence on plan quality and is commendable for the clinical routine. If no kV-modality is available, a daily IGRT scenario with one CBCT per week and planar axial images on the other days should be preferred over daily MV-CBCT.
Collapse
Affiliation(s)
- Katharina Bell
- Department of Radiotherapy and Radiation Oncology, Saarland University Medical Centre, Kirrberger Str. Geb. 6.5, D-66421, Homburg/Saar, Germany.
| | - Marina Heitfeld
- Department of Radiotherapy and Radiation Oncology, Saarland University Medical Centre, Kirrberger Str. Geb. 6.5, D-66421, Homburg/Saar, Germany
| | - Norbert Licht
- Department of Radiotherapy and Radiation Oncology, Saarland University Medical Centre, Kirrberger Str. Geb. 6.5, D-66421, Homburg/Saar, Germany
| | - Christian Rübe
- Department of Radiotherapy and Radiation Oncology, Saarland University Medical Centre, Kirrberger Str. Geb. 6.5, D-66421, Homburg/Saar, Germany
| | - Yvonne Dzierma
- Department of Radiotherapy and Radiation Oncology, Saarland University Medical Centre, Kirrberger Str. Geb. 6.5, D-66421, Homburg/Saar, Germany
| |
Collapse
|
16
|
Poirier Y, Tambasco M. Experimental validation of a kV source model and dose computation method for CBCT imaging in an anthropomorphic phantom. J Appl Clin Med Phys 2016; 17:155-171. [PMID: 27455477 PMCID: PMC5690031 DOI: 10.1120/jacmp.v17i4.6021] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2015] [Revised: 03/15/2016] [Accepted: 02/29/2016] [Indexed: 11/25/2022] Open
Abstract
We present an experimental validation of a kilovoltage (kV) X‐ray source characterization model in an anthropomorphic phantom to estimate patient‐specific absorbed dose from kV cone‐beam computed tomography (CBCT) imaging procedures and compare these doses to nominal weighted CT‐dose index (CTDIw) dose estimates. We simulated the default Varian on‐board imager 1.4 (OBI) default CBCT imaging protocols (i.e., standard‐dose head, low‐dose thorax, pelvis, and pelvis spotlight) using our previously developed and easy to implement X‐ray point‐source model and source characterization approach. We used this characterized source model to compute absorbed dose in homogeneous and anthropomorphic phantoms using our previously validated in‐house kV dose computation software (kVDoseCalc). We compared these computed absorbed doses to doses derived from ionization chamber measurements acquired at several points in a homogeneous cylindrical phantom and from thermoluminescent detectors (TLDs) placed in the anthropomorphic phantom. In the homogeneous cylindrical phantom, computed values of absorbed dose relative to the center of the phantom agreed with measured values within ≤2% of local dose, except in regions of high‐dose gradient where the distance to agreement (DTA) was 2 mm. The computed absorbed dose in the anthropomorphic phantom generally agreed with TLD measurements, with an average percent dose difference ranging from 2.4%±6.0% to 5.7%±10.3%, depending on the characterized CBCT imaging protocol. The low‐dose thorax and the standard dose scans showed the best and worst agreement, respectively. Our results also broadly agree with published values, which are approximately twice as high as the nominal CTDIw would suggest. The results demonstrate that our previously developed method for modeling and characterizing a kV X‐ray source could be used to accurately assess patient‐specific absorbed dose from kV CBCT procedures within reasonable accuracy, and serve as further evidence that existing CTDIw assessments underestimate absorbed dose delivered to patients. PACS number(s): 87.57.Q‐, 87.57.uq, 87.10.Rt
Collapse
|
17
|
Rampado O, Giglioli FR, Rossetti V, Fiandra C, Ragona R, Ropolo R. Evaluation of various approaches for assessing dose indicators and patient organ doses resulting from radiotherapy cone-beam CT. Med Phys 2016; 43:2515. [DOI: 10.1118/1.4947129] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
18
|
Sresty NVNM, Alluri K, Thogata R. A study of X-ray volume imaging system in image guided radiotherapy with variable gantry rotations. INTERNATIONAL JOURNAL OF CANCER THERAPY AND ONCOLOGY 2016. [DOI: 10.14319/ijcto.41.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
19
|
Sresty N, Ramanjappa T. Optimal usage of cone beam computed tomography system with different field of views in image guided radiotherapy (IGRT). INTERNATIONAL JOURNAL OF CANCER THERAPY AND ONCOLOGY 2015. [DOI: 10.14319/ijcto.33.4] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
20
|
Alaei P, Spezi E. Imaging dose from cone beam computed tomography in radiation therapy. Phys Med 2015; 31:647-58. [PMID: 26148865 DOI: 10.1016/j.ejmp.2015.06.003] [Citation(s) in RCA: 94] [Impact Index Per Article: 10.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/17/2015] [Revised: 05/29/2015] [Accepted: 06/05/2015] [Indexed: 12/26/2022] Open
Abstract
Imaging dose in radiation therapy has traditionally been ignored due to its low magnitude and frequency in comparison to therapeutic dose used to treat patients. The advent of modern, volumetric, imaging modalities, often as an integral part of linear accelerators, has facilitated the implementation of image-guided radiation therapy (IGRT), which is often accomplished by daily imaging of patients. Daily imaging results in additional dose delivered to patient that warrants new attention be given to imaging dose. This review summarizes the imaging dose delivered to patients as the result of cone beam computed tomography (CBCT) imaging performed in radiation therapy using current methods and equipment. This review also summarizes methods to calculate the imaging dose, including the use of Monte Carlo (MC) and treatment planning systems (TPS). Peripheral dose from CBCT imaging, dose reduction methods, the use of effective dose in describing imaging dose, and the measurement of CT dose index (CTDI) in CBCT systems are also reviewed.
Collapse
Affiliation(s)
| | - Emiliano Spezi
- School of Engineering, Cardiff University, Cardiff, Wales, UK; Velindre Cancer Centre, Cardiff, Wales, UK
| |
Collapse
|
21
|
Brochu FM, Burnet NG, Jena R, Plaistow R, Parker MA, Thomas SJ. Geant4 simulation of the Elekta XVI kV CBCT unit for accurate description of potential late toxicity effects of image-guided radiotherapy. Phys Med Biol 2014; 59:7601-8. [PMID: 25415354 DOI: 10.1088/0031-9155/59/24/7601] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
This paper describes the modelisation of the Elekta XVI Cone Beam Computed Tomography (CBCT) machine components with Geant4 and its validation against calibration data taken for two commonly used machine setups. Preliminary dose maps of simulated CBCTs coming from this modelisation work are presented. This study is the first step of a research project, GHOST, aiming to improve the understanding of late toxicity risk in external beam radiotherapy patients by simulating dose depositions integrated from different sources (imaging, treatment beam) over the entire treatment plan. The second cancer risk will then be derived from different models relating irradiation dose and second cancer risk.
Collapse
Affiliation(s)
- F M Brochu
- University of Cambridge, Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK. University of Cambridge, Department of Physics, Cavendish Laboratory, J J Thomson Avenue, Cambridge, UK
| | | | | | | | | | | |
Collapse
|
22
|
Image quality and dose distributions of three linac-based imaging modalities. Strahlenther Onkol 2014; 191:365-74. [PMID: 25527311 DOI: 10.1007/s00066-014-0798-7] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2014] [Accepted: 11/24/2014] [Indexed: 10/24/2022]
Abstract
BACKGROUND AND PURPOSE Linac-based patient imaging is possible with a variety of techniques using different photon energies. The purpose of this work is to compare three imaging systems operating at 6 MV, flattening free filter (FFF) 1 MV, and 121 kV. PATIENTS AND METHODS The dose distributions of all pretreatment set-up images (over 1,000) were retrospectively calculated on the planning computed tomography (CT) images for all patients with prostate and head-and-neck cancer treated at our institution in 2013. We analyzed the dose distribution and the dose to organs at risk. RESULTS For head-and-neck cancer patients, the imaging dose from 6-MV cone beam CT (CBCT) reached maximum values at around 8 cGy. The 1-MV CBCT dose was about 63-79 % of the 6-MV CBCT dose for all organs at risk. Planar imaging reduced the imaging dose from CBCT to 30-40 % for both megavoltage modalities. The dose from the kilovoltage CBCT was 4-10 % of the 6-MV CBCT dose. For prostate cancer patients, the maximum dose from 6-MV CBCT reached 13-15 cGy, and was reduced to 66-73 % for 1 MV. Planar imaging reduces the MV CBCT dose to 10-20 %. The kV CBCT dose is 15-20 % of the 6-MV CBCT dose, slightly higher than the dose from MV axes. The dose distributions differ markedly in response to the different beam profiles and dose-depth characteristics.
Collapse
|
23
|
Poirier Y, Kouznetsov A, Koger B, Tambasco M. Experimental validation of a kilovoltage x-ray source model for computing imaging dose. Med Phys 2014; 41:041915. [PMID: 24694146 DOI: 10.1118/1.4869159] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
PURPOSE To introduce and validate a kilovoltage (kV) x-ray source model and characterization method to compute absorbed dose accrued from kV x-rays. METHODS The authors propose a simplified virtual point source model and characterization method for a kV x-ray source. The source is modeled by: (1) characterizing the spatial spectral and fluence distributions of the photons at a plane at the isocenter, and (2) creating a virtual point source from which photons are generated to yield the derived spatial spectral and fluence distribution at isocenter of an imaging system. The spatial photon distribution is determined by in-air relative dose measurements along the transverse (x) and radial (y) directions. The spectrum is characterized using transverse axis half-value layer measurements and the nominal peak potential (kVp). This source modeling approach is used to characterize a Varian(®) on-board-imager (OBI(®)) for four default cone-beam CT beam qualities: beams using a half bowtie filter (HBT) with 110 and 125 kVp, and a full bowtie filter (FBT) with 100 and 125 kVp. The source model and characterization method was validated by comparing dose computed by the authors' inhouse software (kVDoseCalc) to relative dose measurements in a homogeneous and a heterogeneous block phantom comprised of tissue, bone, and lung-equivalent materials. RESULTS The characterized beam qualities and spatial photon distributions are comparable to reported values in the literature. Agreement between computed and measured percent depth-dose curves is ⩽ 2% in the homogeneous block phantom and ⩽ 2.5% in the heterogeneous block phantom. Transverse axis profiles taken at depths of 2 and 6 cm in the homogeneous block phantom show an agreement within 4%. All transverse axis dose profiles in water, in bone, and lung-equivalent materials for beams using a HBT, have an agreement within 5%. Measured profiles of FBT beams in bone and lung-equivalent materials were higher than their computed counterparts resulting in an agreement within 2.5%, 5%, and 8% within solid water, bone, and lung, respectively. CONCLUSIONS The proposed virtual point source model and characterization method can be used to compute absorbed dose in both the homogeneous and heterogeneous block phantoms within of 2%-8% of measured values, depending on the phantom and the beam quality. The authors' results also provide experimental validation for their kV dose computation software, kVDoseCalc.
Collapse
Affiliation(s)
- Yannick Poirier
- CancerCare Manitoba, 675 McDermot Ave, Winnipeg, Manitoba R3E 0V9, Canada
| | - Alexei Kouznetsov
- Department of Physics and Astronomy, University of Calgary, Calgary, Alberta T2N 1N4, Canada
| | - Brandon Koger
- Department of Physics and Astronomy, University of Calgary, Calgary, Alberta T2N 1N4, Canada
| | - Mauro Tambasco
- Department of Physics, San Diego State University, San Diego, California 92182-1233 and Department of Physics and Astronomy and Department of Oncology, University of Calgary, Calgary, Alberta T2N 1N4, Canada
| |
Collapse
|
24
|
Alaei P, Spezi E, Reynolds M. Dose calculation and treatment plan optimization including imaging dose from kilovoltage cone beam computed tomography. Acta Oncol 2014; 53:839-44. [PMID: 24438661 DOI: 10.3109/0284186x.2013.875626] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
BACKGROUND With the increasing use of cone beam computed tomography (CBCT) for patient position verification and radiotherapy treatment adaptation, there is an increasing need to develop techniques that can take into account concomitant dose using a personalized approach. MATERIAL AND METHODS A total of 20 patients (10 pelvis and 10 head and neck) who had undergone radiation therapy using intensity modulated radiation therapy (IMRT) were selected and the dose from kV CBCT was retrospectively calculated using a treatment planning system previously commissioned for this purpose. The imaging dose was added to the CT images used for treatment planning and the difference in its addition prior to and after the planning was assessed. RESULTS The additional isocenter dose as a result of daily CBCT is in the order of 3-4 cGy for 35-fraction head and neck and 23-47 cGy for 25-fraction pelvis cases using the standard head and neck and pelvis image acquisition protocols. The pelvic dose is especially dependent on patient size and body mass index (BMI), being higher for patients with lower BMI. Due to the low energy of the kV CBCT beam, the maximum energy deposition is at or near the surface with the highest dose being on the patient's left side for the head and neck (∼7 cGy) and on the posterior for the pelvic cases (∼80 cGy). Addition of imaging dose prior to plan optimization resulted in an average reduction of 4% in the plan monitor units and 5% in the number of control points. CONCLUSION Dose from daily kV CBCT has been added to patient treatment plans using previously commissioned kV CBCT beams in a treatment planning system. Addition of imaging dose can be included in IMRT treatment plan optimization and would facilitate customization of imaging protocol based on patient anatomy and location of isocenter.
Collapse
Affiliation(s)
- Parham Alaei
- Department of Radiation Oncology, University of Minnesota , Minneapolis, Minnesota , USA
| | | | | |
Collapse
|
25
|
Dosimetry of an In-Line Kilovoltage Imaging System and Implementation in Treatment Planning. Int J Radiat Oncol Biol Phys 2014; 88:913-9. [DOI: 10.1016/j.ijrobp.2013.12.007] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2013] [Revised: 12/02/2013] [Accepted: 12/04/2013] [Indexed: 11/18/2022]
|
26
|
Giaddui T, Cui Y, Galvin J, Yu Y, Xiao Y. Comparative dose evaluations between XVI and OBI cone beam CT systems using Gafchromic XRQA2 film and nanoDot optical stimulated luminescence dosimeters. Med Phys 2014; 40:062102. [PMID: 23718600 DOI: 10.1118/1.4803466] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
PURPOSE To investigate the effect of energy (kVp) and filters (no filter, half Bowtie, and full Bowtie) on the dose response curves of the Gafchromic XRQA2 film and nanoDot optical stimulated luminescence dosimeters (OSLDs) in CBCT dose fields. To measure surface and internal doses received during x-ray volume imager (XVI) (Version R4.5) and on board imager (OBI) (Version 1.5) CBCT imaging protocols using these two types of dosimeters. METHODS Gafchromic XRQA2 film and nanoDot OSLD dose response curves were generated at different kV imaging settings used by XVI (software version R4.5) and OBI (software version 1.5) CBCT systems. The settings for the XVI system were: 100 kVp∕F0 (no filter), 120 kVp∕F0, and 120 kVp∕F1 (Bowtie filter), and for the OBI system were: 100 kVp∕full fan, 125 kVp∕full fan, and 125 kVp∕half fan. XRQA2 film was calibrated in air to air kerma levels between 0 and 11 cGy and scanned using reflection scanning mode with the Epson Expression 10000 XL flat-bed document scanner. NanoDot OSLDs were calibrated on phantom to surface dose levels between 0 and 14 cGy and read using the inLight(TM) MicroStar reader. Both dosimeters were used to measure in field surface and internal doses in a male Alderson Rando Phantom. RESULTS Dose response curves of XRQA2 film and nanoDot OSLDs at different XVI and OBI CBCT settings were reported. For XVI system, the surface dose ranged between 0.02 cGy in head region during fast head and neck scan and 4.99 cGy in the chest region during symmetry scan. On the other hand, the internal dose ranged between 0.02 cGy in the head region during fast head and neck scan and 3.17 cGy in the chest region during chest M20 scan. The average (internal and external) dose ranged between 0.05 cGy in the head region during fast head and neck scan and 2.41 cGy in the chest region during chest M20 scan. For OBI system, the surface dose ranged between 0.19 cGy in head region during head scan and 4.55 cGy in the pelvis region during spot light scan. However, the internal dose ranged between 0.47 cGy in the head region during head scan and 5.55 cGy in the pelvis region during spot light scan. The average (internal and external) dose ranged between 0.45 cGy in the head region during head scan and 3.59 cGy in the pelvis region during spot light scan. Both Gafchromic XRQA2 film and nanoDot OSLDs gave close estimation of dose (within uncertainties) in many cases. Though, discrepancies of up to 20%-30% were observed in some cases. CONCLUSIONS Dose response curves of Gafchromic XRQA2 film and nanoDot OSLDs indicated that the dose responses of these two dosimeters were different even at the same photon energy when different filters were used. Uncertainty levels of both dosimetry systems were below 6% at doses above 1 cGy. Both dosimetry systems gave almost similar estimation of doses (within uncertainties) in many cases, with exceptions of some cases when the discrepancy was around 20%-30%. New versions of the CBCT systems (investigated in this study) resulted in lower imaging doses compared with doses reported on earlier versions in previous studies.
Collapse
Affiliation(s)
- Tawfik Giaddui
- Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
| | | | | | | | | |
Collapse
|